Treatment Registry
TR-0640 ActiveRecorded September 2026

Compounded tirzepatide

Sold by NuuVim · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Price

TermPer monthCharged today
Injectable Tirzepatide, new to GLP-1s (first 3 months)Introductory

“$133 / month $399 Total First 3 months · 3-month billing plan”

Per month$133Charged today$399
Injectable Tirzepatide, standard/renewal rate

“$199.67 / month $599 Total Standard rate · 3-month billing plan”

Per month$199.67Charged today$599
Price sources
Visit NuuVim

We earn nothing from this link. It opens NuuVim's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PharmacyHallandale Pharmacy, Fort Lauderdale FL; VialsRX, Houston TX
StatesAll 50 states
PrescriberAsynchronous review
CancellationSubscription Services automatically renew based on the billing cycle presented during checkout. You may cancel at any time through the patient portal or emailing: support@NuuVim.com .

Not yet checked: membership and consult fee.

Recorded from nuuvim.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — The Oral Tirzepatide SKU has no enum match (no 'oral tirzepatide' drug type exists on this register); recorded as compounded tirzepatide with form sublingual since the page tags it COMPOUNDED and describes it as a sublingual liposomal liquid, same as Oral Semaglutide.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0640
Medication category
compounded tirzepatide
Readings
1

Related records

Other records from NuuVim

All NuuVim programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 374 records of the same molecule.

Cite this entry

Treatment Registry. (2026). NuuVim — compounded tirzepatide (TR-0640). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0640

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.